アジェンダ
10:55 AM — 11:00 AM
11:00 AM — 12:00 PM
Session 1: Updates and Insights from the Office of Combination Products (OCP)12:00 PM — 12:30 PM
1:30 PM — 2:30 PM
3:30 PM — 4:00 PM
4:00 PM — 5:00 PM
Session 4: Device Post-Market Safety Management in a Drug Product World11:05 AM — 11:35 AM
11:35 AM — 12:35 PM
Session 6: Technical and Regulatory Considerations for an On-Body Injector12:35 PM — 1:35 PM
2:35 PM — 3:05 PM